XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert S. who wrote (7764)	11/18/1998 9:16:00 PM
From: aknahow	Read Replies (1) of 17367

I think Tex was on the mark also. We will see what happens if Neuprex is approved for Meningococcemia. Given the implications for its use in sepsis and that indeed the current trial is considered by many to be a proof of concept for sepsis, there is reason to think you are wrong. Ligands drug also is not designed to save lives. If you think people will not get enthused about a drug that saves more kids you are wrong about that too.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next